Joseph Tsui

6.0k total citations
52 papers, 2.7k citations indexed

About

Joseph Tsui is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Joseph Tsui has authored 52 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 8 papers in Molecular Biology. Recurrent topics in Joseph Tsui's work include Neurological disorders and treatments (24 papers), Parkinson's Disease Mechanisms and Treatments (23 papers) and Botulinum Toxin and Related Neurological Disorders (20 papers). Joseph Tsui is often cited by papers focused on Neurological disorders and treatments (24 papers), Parkinson's Disease Mechanisms and Treatments (23 papers) and Botulinum Toxin and Related Neurological Disorders (20 papers). Joseph Tsui collaborates with scholars based in Canada, United States and Denmark. Joseph Tsui's co-authors include Donald B. Calne, Michael Schulzer, Edwin Mak, Susan Calne, Mohit Bhatt, Norman L.M. Wong, Kay Teschke, D. B. Calne, Barry Snow and Stanley A. Hashimoto and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Joseph Tsui

51 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Tsui Canada 28 2.1k 868 351 282 254 52 2.7k
Jose‐Alberto Palma United States 31 1.6k 0.8× 638 0.7× 529 1.5× 271 1.0× 270 1.1× 120 3.0k
Carmel Armon United States 27 1.6k 0.7× 432 0.5× 185 0.5× 338 1.2× 360 1.4× 77 2.7k
Fukashi Udaka Japan 26 1.2k 0.6× 437 0.5× 207 0.6× 260 0.9× 334 1.3× 104 2.2k
F. Carella Italy 28 1.4k 0.6× 515 0.6× 548 1.6× 538 1.9× 376 1.5× 78 2.5k
Jarosław Sławek Poland 32 2.3k 1.1× 809 0.9× 416 1.2× 379 1.3× 444 1.7× 229 3.1k
Federico Micheli Argentina 25 1.7k 0.8× 553 0.6× 239 0.7× 206 0.7× 261 1.0× 107 2.2k
Hideto Miwa Japan 24 1.0k 0.5× 545 0.6× 152 0.4× 221 0.8× 134 0.5× 109 1.7k
Richard B. Dewey United States 29 2.1k 1.0× 925 1.1× 143 0.4× 184 0.7× 287 1.1× 76 2.8k
Monika Rudzińska Poland 23 1.3k 0.6× 491 0.6× 163 0.5× 257 0.9× 233 0.9× 104 1.8k
Timothy L. Williams United Kingdom 21 1.5k 0.7× 412 0.5× 235 0.7× 451 1.6× 128 0.5× 49 2.3k

Countries citing papers authored by Joseph Tsui

Since Specialization
Citations

This map shows the geographic impact of Joseph Tsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Tsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Tsui more than expected).

Fields of papers citing papers by Joseph Tsui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Tsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Tsui. The network helps show where Joseph Tsui may publish in the future.

Co-authorship network of co-authors of Joseph Tsui

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Tsui. A scholar is included among the top collaborators of Joseph Tsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Tsui. Joseph Tsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsui, Joseph, Yuanbing Jiang, Fanny C.F. Ip, et al.. (2025). The TREM2 H157Y variant is associated with more severe neurodegeneration in Alzheimer's disease and altered immune‐related processes. Alzheimer s & Dementia. 21(9). e70586–e70586. 1 indexed citations
2.
3.
Wile, Daryl, Katie Dinelle, Nasim Vafai, et al.. (2015). A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine‐rich repeat kinase 2 mutation carrier. Movement Disorders. 31(3). 405–409. 13 indexed citations
4.
Harris, Marianne, Joseph Tsui, Stephen A. Marion, Hui Shen, & Kay Teschke. (2012). Association of Parkinson's disease with infections and occupational exposure to possible vectors. Movement Disorders. 27(9). 1111–1117. 55 indexed citations
5.
Rugbjerg, Kathrine, Marianne Harris, Hui Shen, et al.. (2011). Pesticide exposure and risk of Parkinson’s disease – a population-based case–control study evaluating the potential for recall bias. Scandinavian Journal of Work Environment & Health. 37(5). 427–436. 40 indexed citations
6.
Kumar, Ajit, Susan Calne, Michael Schulzer, et al.. (2004). Clustering of Parkinson Disease. Archives of Neurology. 61(7). 1057–60. 23 indexed citations
7.
Schulzer, Michael, et al.. (2003). The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology. Parkinsonism & Related Disorders. 9(4). 233–238. 35 indexed citations
8.
Honey, Christopher R., et al.. (2003). Regulation of aquaporin-4 in a traumatic brain injury model in rats. Journal of neurosurgery. 98(3). 565–569. 113 indexed citations
9.
Wong, Norman L.M., et al.. (2003). Attenuation of renal vasopressin V2 receptor upregulation by bosentan, an ETA/ETB receptor antagonist. Metabolism. 52(9). 1141–1146. 15 indexed citations
10.
Wong, Norman L.M. & Joseph Tsui. (2003). Angiotensin II upregulates the expression of vasopressin V2 mRNA in the inner medullary collecting duct of the rat. Metabolism. 52(3). 290–295. 42 indexed citations
11.
Schwartz, Marion, et al.. (2002). Occupational and environmental risk factors for Parkinson's disease. Parkinsonism & Related Disorders. 8(5). 297–309. 127 indexed citations
12.
Calne, Donald B., et al.. (2001). The long-term response to levodopa in dopa-responsive dystonia. Parkinsonism & Related Disorders. 8(1). 1–5. 33 indexed citations
13.
Wong, Norman L.M. & Joseph Tsui. (2001). Angiotensin regulates endothelin-B receptor in rat inner medullary collecting duct. Metabolism. 50(6). 661–666. 15 indexed citations
14.
Tsui, Joseph. (1996). Botulinum toxin as a therapeutic agent. Pharmacology & Therapeutics. 72(1). 13–24. 72 indexed citations
15.
Tsui, Joseph, Barry Snow, & Donald B. Calne. (1992). Reply. Annals of Neurology. 31(1). 113–113. 3 indexed citations
16.
Peppard, Richard, W. R. Wayne Martin, George Carr, et al.. (1992). Cerebral Glucose Metabolism in Parkinson's Disease With and Without Dementia. Archives of Neurology. 49(12). 1262–1268. 121 indexed citations
17.
Snow, Barry, et al.. (1990). Treatment of spasticity with botulinum toxin: A double‐blind study. Annals of Neurology. 28(4). 512–515. 312 indexed citations
18.
Tsui, Joseph, et al.. (1989). The effect of dietary protein on the efficacy of L‐dopa. Neurology. 39(4). 549–549. 46 indexed citations
19.
Teräväinen, H., Joseph Tsui, Edwin Mak, & Donald B. Calne. (1989). Optimal Indices for Testing Parkinsonian Rigidity. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 16(2). 180–183. 36 indexed citations
20.
Tsui, Joseph, Robin D. Fross, Susan Calne, & D. B. Calne. (1987). Local Treatment of Spasmodic Torticollis with Botulinum Toxin. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(S3). 533–535. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jose‐Alberto Palma Breakdown of academic impact, for papers by Carmel Armon Breakdown of academic impact, for papers by Fukashi Udaka Breakdown of academic impact, for papers by F. Carella Breakdown of academic impact, for papers by Jarosław Sławek Breakdown of academic impact, for papers by Federico Micheli Breakdown of academic impact, for papers by Hideto Miwa Breakdown of academic impact, for papers by Richard B. Dewey Breakdown of academic impact, for papers by Monika Rudzińska Breakdown of academic impact, for papers by Timothy L. Williams
Rankless by CCL
2026